J3530 HCPCS code: Nasal vaccine inhalation
J3530 is the HCPCS Level II code for nasal vaccine inhalation. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1986-01-01 |
| Last action effective | 1997-01-01 |
What changed for J3530
- 1986-01-01: J3530 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3530?
J3530 is the HCPCS Level II code for nasal vaccine inhalation. Short descriptor: "Nasal vaccine inhalation".
Does Medicare cover J3530?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
Related J35 codes
- J3520 — Edetate disodium, per 150 mg
- J3535 — Drug administered through a metered dose inhaler
- J3570 — Laetrile, amygdalin, vitamin b17
- J3590 — Unclassified biologics
- J3591 — Unclassified drug or biological used for esrd on dialysis
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3530
- Watch J3530 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3530
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.